(Q51464078)

5 April 2018

title

Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients. (English)

1 reference

5 April 2018

systemic lupus erythematosus

main subject

1 reference

Claudia R L Cardoso

1

1 reference

5 April 2018

Flávio V Signorelli

series ordinal

2

1 reference

5 April 2018

Jose A Papi

series ordinal

3

1 reference

5 April 2018

Gil F Salles

series ordinal

4

1 reference

5 April 2018

publication date

4 September 2007

1 reference

5 April 2018

Rheumatology International

published in

1 reference

5 April 2018

volume

28

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

323-327

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1007/s00296-007-0447-x

exact match

0 references

cites work

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

1 reference

12 December 2020

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

1 reference

12 December 2020

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus

1 reference

12 December 2020

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

1 reference

12 December 2020

The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

12 December 2020

Natural history of hypercholesterolemia in systemic lupus erythematosus

1 reference

12 December 2020

Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Significant predictors of poor prognosis in women aged </=65 years hospitalized for an acute coronary event

1 reference

12 December 2020

The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus

1 reference

12 December 2020

Lipid profiles in patients with systemic lupus erythematosus

1 reference

12 December 2020

The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort

1 reference

12 December 2020

The cardiovascular burden of lupus: a complex challenge

1 reference

12 December 2020

Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

1 reference

12 December 2020

Morbidity in systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S00296-007-0447-X

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

17786449

1 reference

5 April 2018